Hyperosmolar dextrose extravasation can cause progressive bullous and soft tissue injury when sustained peripheral delivery of concentrated solutions escapes into surrounding tissue, according to a clinical report published by medical researchers. In a documented case involving a 44-year-old woman undergoing treatment for suspected endogenous hyperinsulinism, a 20-gauge peripheral intravenous catheter used for continuous 10% dextrose and repeated 50% dextrose boluses resulted in tense fluid-filled bullae and severe forearm swelling that evolved insidiously over several days.
Vascular Access Risks and Hypertonic Solutions
Peripheral catheter infiltration remains a common complication in hospitalized adults. According to pooled data cited in the research, catheters carry a pooled infiltration or extravasation rate of 13.7%. Experimental work in animal models demonstrates that glucose acts as an irritant at certain osmolarities and becomes a vesicant at higher levels, leading to tissue ulceration and necrosis within 24 hours. Standard 10% dextrose has a calculated osmolarity of 505 mOsm/L, whereas 50% dextrose reaches roughly fivefold more concentrated, placing it firmly in the vesicant range.
Did you know? Product labeling and nutrition standards from the American Society for Parenteral and Enteral Nutrition advise utilizing central venous access for any solutions at or above 900 mOsm/L to minimize the risk of phlebitis, vein damage, and localized tissue injury.
Clinical Presentation of Dextrose Extravasation
The patient, admitted after an anterior lumbar interbody fusion (ALIF), experienced recurrent hypoglycemia following a witnessed generalized seizure. Endocrinology consultation and diagnostic evaluations—including unsuppressed insulin of 13 uIU/mL and C-peptide of 4.7 ng/mL at a serum glucose of 55 mg/dL—pointed toward endogenous hyperinsulinism. Management required a multiday continuous 10% dextrose infusion at 150 to 200 mL per hour paired with as-needed 50% dextrose boluses delivered through a single 20-gauge peripheral catheter in the right antecubital fossa.
On hospital day 4, staff identified an infiltrated peripheral catheter site after three days of dwell time, prompting a transfer of the infusion to a peripherally inserted central catheter (PICC). By hospital day 6, two days after catheter removal, multiple tense bullae measuring up to 3 cm appeared over the right anterior forearm along with swelling and erythema.
Management and Prevention Strategies
Researchers note that patients requiring a multiday dextrose bridge for conditions like insulinoma face unique risks due to prolonged cumulative hypertonic exposure. Structured, scheduled infusion site assessments and early consideration of central or midline access are vital safeguards for patients expected to undergo high-concentration intravenous dextrose therapy for extended periods.
Frequently Asked Questions
What osmolarity level makes a dextrose solution a vesicant?
Experimental studies cited in the research indicate that glucose solutions become vesicants above a threshold osmolarity, causing rapid cellular dehydration and capillary endothelial damage.
Why do patients with endogenous hyperinsulinism face higher extravasation risks?
Patients with endogenous hyperinsulinism often require a multiday intravenous dextrose bridge to manage severe hypoglycemia while awaiting tumor localization and definitive surgical treatment, extending their exposure to hypertonic infusions.
How is hyperosmolar dextrose extravasation managed?
Stay Informed on Clinical Safety
Related reading